ADAP – Adaptimmune Therapeutics plc
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Fair Value
Margin Of Safety %
Put/Call OI Ratio
0.13
Float Short %
3.09
EPS 1 Diff
-0.39
EPS Year Diff
0.08
Ticker: ADAP
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | ADAP | 1.08 | 0.09 | 0.00 | 15188 |
| 2024-09-09 | ADAP | 1.1139 | 0.09 | 0.09 | 15195 |
| 2024-09-10 | ADAP | 1.09 | 0.09 | 0.09 | 15195 |
| 2024-09-11 | ADAP | 1.085 | 0.09 | 0.00 | 15151 |
| 2024-09-12 | ADAP | 1.105 | 0.09 | 0.02 | 15158 |
| 2024-09-13 | ADAP | 1.1 | 0.09 | 5.80 | 15240 |
| 2024-09-16 | ADAP | 1.04 | 0.09 | 0.00 | 15184 |
| 2024-09-17 | ADAP | 1.05 | 0.09 | 2.60 | 15187 |
| 2024-09-18 | ADAP | 1.03 | 0.09 | 0.42 | 15192 |
| 2024-09-19 | ADAP | 1.01 | 0.08 | 0.95 | 15020 |
| 2024-09-20 | ADAP | 0.9939 | 0.07 | 0.00 | 14977 |
| 2024-09-23 | ADAP | 0.9381 | 0.06 | 0.01 | 2460 |
| 2024-09-24 | ADAP | 0.9709 | 0.05 | 0.00 | 2717 |
| 2024-09-25 | ADAP | 0.9172 | 0.05 | 0.27 | 2959 |
| 2024-09-26 | ADAP | 0.937 | 0.05 | 0.00 | 3023 |
| 2024-09-27 | ADAP | 0.9724 | 0.05 | 0.00 | 3061 |
| 2024-09-30 | ADAP | 0.9518 | 0.04 | 1.09 | 3396 |
| 2024-10-01 | ADAP | 0.92 | 0.06 | 0.00 | 3472 |
| 2024-10-02 | ADAP | 0.8888 | 0.06 | 5.04 | 3496 |
| 2024-10-03 | ADAP | 0.9017 | 0.13 | 0.05 | 3797 |
| 2024-10-04 | ADAP | 0.9553 | 0.13 | 0.88 | 3801 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | ADAP | 1.09 | 25.0 | - | -0.46 |
| 2024-09-09 | ADAP | 1.10 | 25.0 | - | -0.46 |
| 2024-09-10 | ADAP | 1.08 | 25.0 | - | -0.46 |
| 2024-09-11 | ADAP | 1.08 | 25.0 | - | -0.46 |
| 2024-09-12 | ADAP | 1.10 | 25.0 | - | -0.46 |
| 2024-09-13 | ADAP | 1.11 | 25.0 | - | -0.46 |
| 2024-09-16 | ADAP | 1.04 | 25.0 | - | -0.46 |
| 2024-09-17 | ADAP | 1.05 | 25.0 | - | -0.46 |
| 2024-09-18 | ADAP | 1.04 | 25.0 | - | -0.46 |
| 2024-09-19 | ADAP | 1.01 | 25.0 | - | -0.46 |
| 2024-09-20 | ADAP | 0.99 | 25.0 | - | -0.46 |
| 2024-09-23 | ADAP | 0.94 | 25.0 | - | -0.46 |
| 2024-09-24 | ADAP | 0.97 | 25.0 | - | -0.46 |
| 2024-09-25 | ADAP | 0.92 | 25.0 | - | -0.46 |
| 2024-09-26 | ADAP | 0.94 | 25.0 | - | -0.46 |
| 2024-09-27 | ADAP | 0.98 | 25.0 | - | -0.46 |
| 2024-09-30 | ADAP | 0.95 | 25.0 | - | -0.46 |
| 2024-10-01 | ADAP | 0.93 | 25.0 | - | -0.46 |
| 2024-10-02 | ADAP | 0.89 | 25.0 | - | -0.46 |
| 2024-10-03 | ADAP | 0.90 | 25.0 | - | -0.46 |
| 2024-10-04 | ADAP | 0.95 | 25.0 | - | -0.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | ADAP | -0.08 | -0.50 | 3.15 |
| 2024-09-09 | ADAP | -0.08 | -0.50 | 3.15 |
| 2024-09-10 | ADAP | -0.08 | -0.50 | 3.15 |
| 2024-09-11 | ADAP | -0.08 | -0.50 | 3.15 |
| 2024-09-12 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-13 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-16 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-17 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-18 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-19 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-20 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-23 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-24 | ADAP | -0.08 | -0.50 | 3.02 |
| 2024-09-25 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-09-26 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-09-27 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-09-30 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-10-01 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-10-02 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-10-03 | ADAP | -0.08 | -0.50 | 3.09 |
| 2024-10-04 | ADAP | -0.08 | -0.50 | 3.09 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.27
Avg. EPS Est. Current Quarter
-0.15
Avg. EPS Est. Next Quarter
-0.12
Insider Transactions
-0.08
Institutional Transactions
-0.5
Beta
2.22
Average Sales Estimate Current Quarter
11
Average Sales Estimate Next Quarter
12
Fair Value (Academic)
Quality Score
14
Growth Score
41
Sentiment Score
40
Actual DrawDown %
92.9
Max Drawdown 5-Year %
-96.5
Target Price
3.06
P/E
Forward P/E
PEG
P/S
1.72
P/B
2.53
P/Free Cash Flow
EPS
-0.35
Average EPS Est. Cur. Y
-0.46
EPS Next Y. (Est.)
-0.43
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-51.25
Relative Volume
0.41
Return on Equity vs Sector %
-96.9
Return on Equity vs Industry %
-118.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
stock quote shares ADAP – Adaptimmune Therapeutics plc Stock Price stock today
news today ADAP – Adaptimmune Therapeutics plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADAP – Adaptimmune Therapeutics plc yahoo finance google finance
stock history ADAP – Adaptimmune Therapeutics plc invest stock market
stock prices ADAP premarket after hours
ticker ADAP fair value insiders trading